Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Differences in risk factors for breast cancer molecular subtypes in a population-based study.

Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, Hewitt SM, Anderson WF, Szeszenia-Dabrowska N, Bardin-Mikolajczak A, Zatonski W, Cartun R, Mandich D, Rymkiewicz G, Ligaj M, Lukaszek S, Kordek R, García-Closas M.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):439-43.

2.

Association between common risk factors and molecular subtypes in breast cancer patients.

Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, Arik Z, Babacan T, Ozisik Y, Altundag K.

Breast. 2013 Jun;22(3):344-50. doi: 10.1016/j.breast.2012.08.005. Epub 2012 Sep 14.

PMID:
22981738
3.

Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer.

Tamimi RM, Colditz GA, Hazra A, Baer HJ, Hankinson SE, Rosner B, Marotti J, Connolly JL, Schnitt SJ, Collins LC.

Breast Cancer Res Treat. 2012 Jan;131(1):159-67. doi: 10.1007/s10549-011-1702-0. Epub 2011 Aug 10.

4.

Immunohistochemistry-based subtyping of breast carcinoma in Egyptian women: a clinicopathologic study on 125 patients.

Elesawy BH, Abd El hafez A, Shawky Ael-A, Arafa M.

Ann Diagn Pathol. 2014 Feb;18(1):21-6. doi: 10.1016/j.anndiagpath.2013.10.005. Epub 2013 Oct 30.

PMID:
24321463
5.

Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis.

Del Casar JM, Martín A, García C, Corte MD, Alvarez A, Junquera S, González LO, Bongera M, García-Muñiz JL, Allende MT, Vizoso F.

Eur J Obstet Gynecol Reprod Biol. 2008 Dec;141(2):147-52. doi: 10.1016/j.ejogrb.2008.07.021. Epub 2008 Sep 2.

PMID:
18768247
6.

Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies.

Sisti JS, Collins LC, Beck AH, Tamimi RM, Rosner BA, Eliassen AH.

Int J Cancer. 2016 May 15;138(10):2346-56. doi: 10.1002/ijc.29968. Epub 2016 Feb 8.

7.

A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments.

Wang Y, Yin Q, Yu Q, Zhang J, Liu Z, Wang S, Lv S, Niu Y.

Breast Cancer Res Treat. 2011 Nov;130(2):489-98. doi: 10.1007/s10549-011-1709-6. Epub 2011 Aug 12.

PMID:
21837481
8.

Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.

Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

J Surg Res. 2007 Nov;143(1):109-18.

PMID:
17950079
9.

Reproductive history and the risk of molecular breast cancer subtypes in a prospective study of Norwegian women.

Horn J, Opdahl S, Engstrøm MJ, Romundstad PR, Tretli S, Haugen OA, Bofin AM, Vatten LJ, Åsvold BO.

Cancer Causes Control. 2014 Jul;25(7):881-9. doi: 10.1007/s10552-014-0388-0. Epub 2014 May 1.

PMID:
24789514
10.

Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study.

Zhou W, Jirström K, Johansson C, Amini RM, Blomqvist C, Agbaje O, Wärnberg F.

BMC Cancer. 2010 Nov 30;10:653. doi: 10.1186/1471-2407-10-653.

11.

Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.

Marotti JD, Collins LC, Hu R, Tamimi RM.

Mod Pathol. 2010 Feb;23(2):197-204. doi: 10.1038/modpathol.2009.158. Epub 2009 Nov 6.

12.

Identification of a basal-like subtype of breast ductal carcinoma in situ.

Livasy CA, Perou CM, Karaca G, Cowan DW, Maia D, Jackson S, Tse CK, Nyante S, Millikan RC.

Hum Pathol. 2007 Feb;38(2):197-204.

PMID:
17234468
13.

Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea.

Park B, Choi JY, Sung HK, Ahn C, Hwang Y, Jang J, Lee J, Kim H, Shin HR, Park S, Han W, Noh DY, Yoo KY, Kang D, Park SK.

Medicine (Baltimore). 2016 Apr;95(14):e3063. doi: 10.1097/MD.0000000000003063.

14.

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, Moore DT, Perou CM.

Mod Pathol. 2006 Feb;19(2):264-71.

15.

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.

Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML, Perou CM.

Clin Cancer Res. 2007 Apr 15;13(8):2329-34.

16.

Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers.

Yang XR, Figueroa JD, Falk RT, Zhang H, Pfeiffer RM, Hewitt SM, Lissowska J, Peplonska B, Brinton L, Garcia-Closas M, Sherman ME.

Breast Cancer Res. 2012 Apr 18;14(2):R64.

17.
18.

Breast cancer subtypes and the risk of local and regional relapse.

Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H.

J Clin Oncol. 2010 Apr 1;28(10):1684-91. doi: 10.1200/JCO.2009.24.9284. Epub 2010 Mar 1.

PMID:
20194857
19.

Clinicopathologic features and five years survival analysis in molecular subtypes of breast cancer.

Zaha DC, Lazăr E, Lăzureanu C.

Rom J Morphol Embryol. 2010;51(1):85-9.

20.

Risk factors for HR- and HER2-defined breast cancer in Slovenian postmenopausal women.

Cerne JZ, Ferk P, Frkovic-Grazio S, Leskosek B, Gersak K.

Climacteric. 2012 Feb;15(1):68-74. doi: 10.3109/13697137.2011.609286. Epub 2011 Dec 1.

PMID:
22132797

Supplemental Content

Support Center